Clinical Trials Directory

Trials / Completed

CompletedNCT04590287

ICF in Secondary Prevention of Cardiovascular Disease

The Use of ICF Classification System in Secondary Prevention of Cardiovascular Disease Among Others Ischemic and Hemorrhagic Stroke.

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
Poznan University of Medical Sciences · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to develop a practical protocol based on the ICF(The International Classification of Functioning, Disability, and Health) the risk factors of cardiovascular disease (CVD) in secondary prevention.

Detailed description

The original ICF assessment sheet contains CVD risk factor categories, such as comorbidities (depressive disorders, insomnia, heart rhythm and heart rate disorders, carotid artery disease, and hypertension), measures of liver and renal impairment, disorders of carbohydrate and lipid metabolism). The evaluation criteria for each category were determined based on recommendations defined in the ESC, AHA, EFSD, and KIDIGO guidelines.

Conditions

Timeline

Start date
2020-08-15
Primary completion
2020-10-01
Completion
2020-10-01
First posted
2020-10-19
Last updated
2020-10-19

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04590287. Inclusion in this directory is not an endorsement.